Login to your account

Username *
Password *
Remember Me

UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week

UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week – CNN Press release: UK medicines regulator gives approval for first UK COVID-19 vaccine – Medicines and Healthcare products Regulatory Agency See also: Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK – BBC AND Expert reaction to news that […]

The post UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week appeared first on Links Medicus.

Review: Cytokine Storm

Cytokine Storm – New England Journal of Medicine   Commentary on Twitter Cytokine storm is a prominent feature in severe #COVID19. This new @NEJM review on it is as good as it gets. By @DavidFajgenbaum @carlhjune @PennMedicine https://t.co/a4qE7xGR58 pic.twitter.com/Ul1HrnL8Ve — Eric Topol (@EricTopol) December 2, 2020  

The post Review: Cytokine Storm appeared first on Links Medicus.

WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results – New England Journal of Medicine Audio Interview: Caring for Hospitalized Patients with Covid-19   Commentary on Twitter (thread – click for more) The biggest multinational pandemic randomised trial #SOLIDARITYtrial published in the New England Journal of Medicine. https://t.co/VbpbpziFwm WHO, trial leaders, numerous countries, […]

The post WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19 appeared first on Links Medicus.

Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer – New England Journal of Medicine  

The post Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer appeared first on Links Medicus.

Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”

Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review – The Journal of Infectious Diseases   Commentary on Twitter Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review https://t.co/lmWQNgpIfd Existing evidence supports the wide-held belief that the the risk of #SARSCoV2 transmission is lower outdoors (< 10%). — Carlos del Rio […]

The post Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)” appeared first on Links Medicus.

What’s the difference between viral shedding and reinfection with COVID-19?

What’s the difference between viral shedding and reinfection with COVID-19? – The Conversation  

The post What’s the difference between viral shedding and reinfection with COVID-19? appeared first on Links Medicus.

Critically ill patients with COVID-19: A narrative review on prone position

Critically Ill Patients with COVID-19: A Narrative Review on Prone Position – Pulmonary Therapy  

The post Critically ill patients with COVID-19: A narrative review on prone position appeared first on Links Medicus.

Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial – University of Oxford Commentary: Gout drug Colchicine to be tested as COVID-19 treatment in UK trial – Reuters  

The post Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial appeared first on Links Medicus.

Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data

Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data – BMJ Opinion  

The post Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data appeared first on Links Medicus.

Moderna released more Covid-19 vaccine results. They’re very encouraging.

Moderna released more Covid-19 vaccine results. They’re very encouraging. – Vox News release: Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization Commentaries: ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 – Science AND […]

The post Moderna released more Covid-19 vaccine results. They’re very encouraging. appeared first on Links Medicus.

Recherche